Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 319 results for "lupin ltd"

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin Pulls 9000+ Bottles of Suprax From U.S. Market

MUMBAI (Reuters) - India's Lupin Ltd is recalling 9,210 bottles of the cephalosporin antibiotic Suprax (cefixime) which failed a purity test in the United States, the U.S. Food and Drug Administration said. The Suprax recall is the second for ... Diabetes Care, 3 days ago

12 images for lupin ltd

Sify, 5 days ago
Business Today India, 6 days ago, 5 days ago
Sify, 1 month ago
Afternoon Despatch & Courier, 1 month ago
Afternoon Despatch & Courier, 2 months ago
Financial Express, 2 months ago
Sify, 2 months ago
ABC News 4 Charleston, 2 months ago, 4 months ago

Lupin : gets USFDA nod to make generic of Takeda's diabetes drug

Mumbai : Lupin Pharmaceuticals Inc (LPI), the US subsidiary of Indian drug maker Lupin Ltd , has received final approval from the United States Food and Drugs Administration (USFDA) to sell generic diabetes management drug Pioglitazone Tablets in ...
 4 Traders1 week ago LUPIN : Gets nod for diabetes drug  4 Traders1 week ago Lupin Ltd. - Lupin Receives FDA Approval for Generic Actos...  SBICAP Securities1 week ago Lupin receives final USFDA approval for Takeda's Generic Actos® Tablets  Equity Bulls1 week ago

LUPIN : Recalls two lots of suprax

04/16/2014 | 02:28am US/Eastern Recommend: 0 Lupin Ltd is voluntarily recalling two lots of its antibiotic drug, Suprax, in the US market. Its subsidiary, Lupin Pharmaceuticals Inc, is recalling 9,210 bottles of Suprax for not ...
 4 Traders4 days ago

Actavis enters into settlement agreement with Mylan and Famy Care

Actavis plc, a specialty pharmaceutical company, has entered into an agreement with Mylan Inc. and Famy Care Ltd. to settle all outstanding patent litigation related to Mylan's generic version of Generess FE. Under the terms of the agreement, ...
 Individual.com2 days ago Actavis: Agreement Over Generess FE Patent Challenge Litigation  RTTNews.com4 days ago Actavis Announces Agreement Related to Generess FE Patent Challenge Litigation  Pharmacy Choice4 days ago

Stock market live: Sensex falls over 100 points; Ranbaxy falls 5%

12:05 p.m. Top brokerage calls CLSA maintains buy on Lupin , target at Rs 1,155 Ambit maintains sell on Polaris , target at Rs 161 ( More brokerage calls ) 11:45 a.m. Market update: Sensex and Nifty down nearly 0.5 per cent in noon ...
 NDTV1 week ago Stock market live: Sensex recovered from day lows, Infosys up 1.5%  NDTV5 days ago
SPi World News

India's Lupin Recalls Drugs in U.S.

World News: 13:15 GMT Monday 14th April 2014 . [ Wall Street Journal US Business News Feed via SPi World News ] This story Indian drug maker Lupin Ltd.'s U.S. unit is recalling thousands of bottles of one of its Indian-made antibacterial drugs ...
 SPi World News6 days ago

Some generic drugs have had eye-popping price spikes [Fort Worth Star-Telegram :: ]

April 19Pharmacist Larry Cowan can flip through his records and spot the generic drugs that have taken big price jumps in the past year or so. There's digoxin, a heart medicine that he used to buy for pennies a pill. "Now the price is close to ...
 Pharmacy Choice6 hours ago

Opening Bell 15 April | Infosys results to set market mood

Inflation in India is expected to have edged up on higher food costs in March, snapping a three-month easing trend. Wholesale prices probably rose 5.30% in March, faster than the 4.68% rise in February. Photo: Mint Infosys Ltd is set to announce ...
 Livemint.com5 days ago

Pharma sales to rise by over one- fifth in March quarter

The pharma sector's growth had been affected by the effect of the government's new drug pricing policy. Photo: AFP The domestic pharmaceutical market did better in the March quarter, relative to the December quarter, with volume sales rising by ...
 Livemint.com5 days ago
Business Standard

Lupin plans to expand Vadodara plant to make antibiotics

Mumbai-based pharma player Lupin Ltd, is all set to expand its Vadodara facility to make bulk drugs for cardiac, anti-infectives, anti-tuberculosis, neurology and other segments. The estimated project cost is around Rs 270 crore. The Dabhasa plant ...
 Business Standard1 month ago Lupin to expand Vadodara facility  Business Standard India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less